Updated
Gossamer BioGOSS · Healthcare
$9.77+3.72%
Market cap$4.8B
IndustryBiotechnology
Gossamer Bio (GOSS) Superinvestor holders
10 of the superinvestors we track hold Gossamer Bio (GOSS) in their latest 13F filings, $15M in total.
Summary
The largest holder is David Shaw (D. E. Shaw & Co.), with $7M, 0.0% of the portfolio.
In their latest quarter: 2 opened a new position, 5 added, 2 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| David Shaw D. E. Shaw & Co. |
Added | 40,959,285 | $7M | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 15,629,993 | $3M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Added | 11,629,896 | $2M | 0.0% | Q2 2026 |
| Arrowstreet Capital | New position | 7,573,388 | $1M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 7,432,001 | $1M | 0.0% | Q2 2026 |
| Zhang Lei Hillhouse (HHLR Advisors) |
Held | 4,974,041 | $818,727 | 0.1% | Q2 2026 |
| Paul Marshall Marshall Wace |
New position | 2,114,988 | $338,399 | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 1,450,979 | $238,831 | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Added | 479,581 | $78,939 | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Trimmed | 4,468 | $52,000 | 0.0% | Q3 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 10 |
| Q1 2026 | 8 |
| Q4 2025 | 10 |
| Q3 2025 | 10 |
| Q2 2025 | 8 |
| Q1 2025 | 9 |
| Q4 2024 | 7 |
| Q3 2024 | 7 |
Questions about Gossamer Bio
Which superinvestors own Gossamer Bio?
10 of the superinvestors we track hold Gossamer Bio (GOSS) in their latest 13F filings, $15M in total. David Shaw, Cliff Asness, Jim Simons, Arrowstreet Capital, Two Sigma, Zhang Lei.
Who is the largest superinvestor holder of GOSS?
The largest holder is David Shaw (D. E. Shaw & Co.), with $7M, 0.0% of the portfolio.
From Gossamer Bio's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.